This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Jane Wang, Ph.D.
Executive Director of Delivery Technologies at Tessera Therapeutics


Jane joined the Tessera team in 2021 and is currently Executive Director, Head of Delivery Technologies. Prior to joining Tessera, she was technical lead of the nanoparticle program at Verily Life Sciences, where she worked on a variety of delivery technologies including LNP barcoding and extrahepatic nanoparticle delivery. Her background is in drug delivery, chemistry and enzyme engineering and she holds a PhD in Chemistry from UC Berkeley and a BS from the California Institute of Technology in Chemistry.

Agenda Sessions

  • Chairperson Remarks

  • Delivering Mobile Genetic Elements to Write DNA Sequences with RNA